Skip to content

Virtual Reality Training for Upper Extremity After Stroke

Virtual Reality Based Training - a Motivating and Effective Way of Regaining Arm Motor Function After Stroke? The VIRTUES Trial: A Multi-center RCT

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02079103
Acronym
VIRTUES
Enrollment
120
Registered
2014-03-05
Start date
2014-03-31
Completion date
2016-08-31
Last updated
2016-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Virtual reality, Stroke, Arm motor function, Neurorehabilitation

Brief summary

Background: High intensity training of challenging tasks with many repetitions is a key factor for regaining motor function after stroke. Novel virtual reality (VR) rehabilitation systems provide the potential to increase intensity and offer challenging and motivating tasks. The efficacy of VR systems has not been demonstrated yet in sufficiently powered studies. Methods: In 5 participating rehabilitation centers patients in the subacute phase after stroke will be randomized to either a group receiving 4 weeks of VR training in addition to conventional arm training or a group receiving dose-matched and therapist attention-matched conventional arm-training. Hypothesis: VR training is more effective in improving arm motor function than conventional arm training in the subacute phase after stroke.

Detailed description

Background: Approximately two thirds of patients with stroke experience impaired arm motor function, which compromises independence in activities of daily living, occupational areas and quality of life. High intensity training of challenging tasks with many repetitions are key factors for regaining motor function after stroke. Novel virtual reality (VR) rehabilitation systems provide the potential to increase intensity and offer challenging and motivating tasks. The efficacy of VR systems has not been demonstrated yet in sufficiently powered studies. Methods: In this study 120 patients in 5 participating Norwegian, Danish and Belgian rehabilitation institutions will be randomized to either a group receiving VR training in addition to conventional arm training or a group receiving dose-matched and therapist attention-matched conventional arm-training. During a period of 4 weeks the patients will be offered additional 4-5 training sessions weekly of 45-60 minutes duration by a physiotherapist or an occupational therapist. Arm motor function, dexterity and independence in daily life activities will be evaluated at baseline, post and 3 months follow-up assessments with the Action Research Arm Test, Box and Blocks Test and the Functional Independence Measure. Patient satisfaction and therapist satisfaction with the implementation of a new technology based rehabilitation system will also be assessed with questionnaires and interviews. Objective: The objective of the VIRTUES trial is to study the effectiveness and acceptance of a novel VR training approach. The study will provide evidence-based knowledge of new virtual reality based treatment strategies to clinicians, patients and health economists.

Interventions

DEVICEVirtual Reality

During a 4 weeks period the patients will be offered 4-5 Virtual reality training sessions weekly of 45-60 minutes duration in addition to other rehabilitation. The Virtual reality training will be supervised by a physical or an occupational therapist. Virtual reality gaming parameters are adapted according to improving arm motor function.

BEHAVIORALConventional arm training

During a 4 weeks period the patients will be offered 4-5 supervised self-training sessions weekly of 45-60 minutes duration in addition to other rehabilitation. The training will be task-related and supervised by a physical or an occupational therapist. Exercises increase in difficulty according to improving arm motor function.

Sponsors

Haukeland University Hospital
CollaboratorOTHER
Sunnaas Rehabilitation Hospital
CollaboratorOTHER
Regionshospitalet Hammel Neurocenter
CollaboratorOTHER
Regionshospitalet Viborg, Skive
CollaboratorOTHER
KU Leuven
CollaboratorOTHER
Jessa Hospital
CollaboratorOTHER
The Research Council of Norway
CollaboratorOTHER
Helse Vest
CollaboratorOTHER
Norwegian Fund for Postgraduate Training in Physiotherapy
CollaboratorOTHER
University of Bergen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* First ever ischemic or hemorrhagic stroke or former stroke without any residual motor impairment * 1 - 12 weeks post stroke * Impaired arm motor function but some residual arm motor activity as defined by a score of less than 52 on Action Research Arm Test (ARAT), and the ability to execute at least 20 degrees of active shoulder extension and abduction against gravity.

Exclusion criteria

* Severe cognitive impairment defined as \< 20 on Mini Mental Status Examination * Orthopedic impairment, limiting mobility substantially or causing pain * Visual disorders limiting the ability to comply with treatment regimen - \< 18 years * Unable to give informed consent

Design outcomes

Primary

MeasureTime frameDescription
Change in Action Research Arm Test score from baselineBaseline, after 4 weeks and at 3 months follow-upAssessment of changes in arm motor function from baseline to 3 months follow up

Secondary

MeasureTime frameDescription
Change in Box and Blocks Test score from baselineBaseline, after 4 weeks, and at 3 months follow-upAssessment of dexterity
Change in Functional Independence Measure from baselineBaseline, after 4 weeks, and 3 months follow-upAssessment of independence in daily life activities
ABILHAND questionnaireAfter 4 weeks of intervention and at 3 months follow-upSelf-reported use of both hands in daily life activities

Countries

Belgium, Denmark, Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 19, 2026